Pancreatic Cancer Research

ResearcherNational Tsing Hua UniversityActive in the last 2 years

Yiwen Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9008-8346; OpenAlex author ID A5100439335. Sources: OpenAlex.

Their work

Papers
5
Trials
0
Grants
0
Labs led
0
Collaborators
23
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 5

  1. Efficacy of Neoadjuvant Therapy and the Prognostic Significance of Serum Carcinoembryonic Antigen Level in Patients with Localized Pancreatic Adenocarcinoma wi… Co-author DOI 10.1097/sla.0000000000006719↗
  2. Neoadjuvant chemotherapy for primary resectable pancreatic cancer: a systematic review and meta-analysis. Co-author DOI 10.1016/j.hpb.2020.01.001↗
  3. Association of Modified-FOLFIRINOX-Regimen-Based Neoadjuvant Therapy with Outcomes of Locally Advanced Pancreatic Cancer in Chinese Population. Co-author DOI 10.1634/theoncologist.2018-0696↗
  4. The hepatitis B virus X protein promotes pancreatic cancer through modulation of the PI3K/AKT signaling pathway. Co-author DOI 10.1016/j.canlet.2016.06.011↗
  5. Proteomic analysis of gemcitabine-induced drug resistance in pancreatic cancer cells. Co-author DOI 10.1039/c1mb05125c↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xueli Bai · 3 shared papers, 2019–2025 · strength 0.42
  2. Tingbo Liang · 2 shared papers, 2020–2025 · strength 0.35
  3. Qi Zhang · 3 shared papers, 2016–2020 · strength 0.25
  4. Guoliang Qiao · 1 shared paper, 2025 · strength 0.22
  5. Xiang Li Ma · 1 shared paper, 2025 · strength 0.22
  6. Louisa Bolm · 1 shared paper, 2025 · strength 0.22
  7. Zhiyong Yang · 1 shared paper, 2025 · strength 0.22
  8. Motaz Qadan · 1 shared paper, 2025 · strength 0.22
  9. Keith D. Lillemoe · 1 shared paper, 2025 · strength 0.22
  10. Xiang Li · 2 shared papers, 2019–2020 · strength 0.20
  11. Qihan Fu · 2 shared papers, 2016–2020 · strength 0.18
  12. Tingbo Liang · 2 shared papers, 2016–2019 · strength 0.13
  13. Mao Ye · 1 shared paper, 2020 · strength 0.13
  14. Ying Yuan · 1 shared paper, 2019 · strength 0.08
  15. Jianying Lou · 1 shared paper, 2019 · strength 0.08
  16. Qichun Wei · 1 shared paper, 2019 · strength 0.08
  17. Pintong Huang · 1 shared paper, 2019 · strength 0.08
  18. Risheng Que · 1 shared paper, 2019 · strength 0.08
  19. Yinan Shen · 1 shared paper, 2019 · strength 0.08
  20. Ri‐Sheng Yu · 1 shared paper, 2019 · strength 0.08
  21. Xu Dong Sun · 1 shared paper, 2016 · strength 0.05
  22. Xueli Bai · 1 shared paper, 2016 · strength 0.05
  23. Hong‐Lin Chan · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.